Conclusion of a non-exclusive discount agreement in accordance with Section 130a (8) SGB V for medicinal products with the active ingredient Filgrastim (ATC code: L03AA02) within the period from December 1, 2020 to November 30, 2022 with the option of concluding a contract at any time during the term ("open- house model ").
The contractual partners can be viewed at: https://www.aok-gesundheitpartner.de/nds/arzneimittel/rabatt/index_03504.html?bl=nds
The AOK - Die Gesundheitskasse für Niedersachsen intends to enter into force of exclusive contracts after a public tender according to the regulations of the 4th part of the GWB, non-exclusive drug discount contracts for the active ingredient filgrastim (ATC code: L03AA02) with as many market participants as possible (pharmaceutical companies or communities pharmaceutical company) in the so-called "open-house model".
AOK Niedersachsen will not make a selection decision and will make an identical contract offer to every interested pharmaceutical company. In the open-house model, uniform conditions apply to all participants. The content of the contract, terms and conditions and access procedures are uniform - individual negotiations are generally not conducted. The contract terms are a maximum of twenty-four months, the earliest contract start is December 1st, 2020. All contracts end on November 30th, 2022 at the latest, regardless of the date of the respective conclusion of the contract. Joining or entering into a contract can take place within the 24-month period on the first of each month. There is a right of termination six weeks to the end of the month. The AOK - Die Gesundheitskasse für Niedersachsen reserves the right to replace the non-exclusive open-house discount contracts with exclusive discount contracts during the contract period. With the entry into force of advertised, exclusive discount contracts, the open-house contracts are terminated in accordance with the contractual provisions, ie the open-house contracts end automatically. According to the experience of AOK Niedersachsen, exclusive discount agreements usually come into force six to eight months after the publication of the corresponding announcement in the supplement to the Official Journal of the European Union. The future contractual partners in the open-house model are asked to regularly inform themselves about these announcements in the supplement to the Official Journal of the European Union.
Interested pharmaceutical companies can request the contractual documents and the contractual terms and conditions at the contact address given under I.1).
Contracts for the active ingredient Filgrastim (ATC code: L03AA02) will be concluded for the first time with effect from December 1, 2020. Interested parties who would like to become a contractual partner on this date must submit the contract documents to the address specified in the contract documents by October 27, 2020. It depends on the access at the AOK Lower Saxony. Later contracts are possible during the 24-month maximum term on the first of each month. Organizationally, a lead time of usually 35 calendar days on the part of the AOK is necessary in order to carry out the necessary work, e.g. B. to be able to guarantee the contract report in the Lauer-Taxe®. The exact deadlines for receipt will be announced with the contract documents. The present publication does not concern the award of a public contract within the meaning of Directive (2014/24 / EU) or public procurement law. In order to ensure the greatest possible degree of transparency for the intended conclusion of contracts, they are published in the supplement to the Official Journal of the European Union. In the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the procedure designation "open procedure", are solely due to the use of this announcement form and the publication platform. A further meaning, in particular submission to regulations under public procurement law, unless they are mandatory for legal reasons, is not associated with this.